Previous close | 1.3100 |
Open | 1.3300 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 1.3100 - 1.4000 |
52-week range | 1.0300 - 2.2100 |
Volume | |
Avg. volume | 137,601 |
Market cap | 160.56M |
Beta (5Y monthly) | 1.12 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Significant insider control over Biodesix implies vested interests in company growth 53% of the business...
Biodesix, Inc. (NASDAQ:BDSX) Q4 2023 Earnings Call Transcript March 1, 2024 Biodesix, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.11. BDSX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for standing by. […]
Biodesix ( NASDAQ:BDSX ) Full Year 2023 Results Key Financial Results Revenue: US$49.1m (up 28% from FY 2022). Net...